As you may know, Dimerix was pleased to release positive results for our DMX-200 Phase 2a trial in Chronic Kidney Disease (CKD) on 12 July 2017.
You can see that announcement here.
Following the data release, a number of media outlets featured Dimerix’s results.
We have provided a recap below for your interest.
Reuters, 12 July 2017